S. Kullman

"The Göteborg quality of life instrument"--an assessment of well-being and symptoms among men born 1913 and 1923. Methods and validity.

K. Svärdsudd, G. Tibblin, B. Tibblin, 1990, Scandinavian journal of primary health care. Supplement.

Traditional risk-factor profile fails to explain striking geographical differences in IHD mortality among middle-aged men. The project "myocardial infarction in mid-Sweden".

G. Alfthan, C. Nerbrand, S. Kullman, 1992, Scandinavian journal of primary health care.

Differences in perceived symptoms/quality of life in untreated hypertensive and normotensive men.

K. Svärdsudd, S. Kullman, 1990, Scandinavian journal of primary health care. Supplement.

Health care utilisation before and after retirement due to illness. A 13-year population-based follow-up study of prematurely retired men and referents from the general population.

K. Svärdsudd, S. Kullman, T. Wallman, 2004, Scandinavian journal of primary health care.

Swedish Isradipine Study in Hypertension: Evaluation of Quality of Life, Safety, and Efficacy

R. Eggertsen, L. Hansson, B. Dahlöf, 1991, Journal of cardiovascular pharmacology.

NEW DESIGN FOR CLINICAL TRIAL OF ANTIHYPERTENSIVE DRUGS APPLIED TO PINDOLOL, CLOPAMIDE, AND COMBINATIONS THEREOF

G. Nyberg, J. Lessem, J. Leppert, 1982, The Lancet.

Are regional variations in ischaemic heart disease related to differences in coronary risk factors? The project 'myocardial infarction in mid-Sweden'.

K. Svärdsudd, C. Nerbrand, G. Tibblin, 1991, European heart journal.

Antihypertensive Effect of Felodipine or Hydralazine When Added to β‐Blocker Therapy

L. Hansson, J. Leppert, T. Gudbrandsson, 1988, Journal of cardiovascular pharmacology.